An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response
暂无分享,去创建一个
[1] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[2] A. Hanlon,et al. Hypoxic regions exist in human prostate carcinoma. , 1999, Urology.
[3] T K Lewellen,et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.
[4] R. Wasserman,et al. A patient-specific in vivo tumor model. , 1996, Mathematical biosciences.
[5] H Treuer,et al. Reoxygenation of hypoxic cells by tumor shrinkage during irradiation. A computer simulation. , 1995, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[6] A. van Waarde,et al. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] X Allen Li,et al. BGRT: biologically guided radiation therapy-the future is fast approaching! , 2007, Medical physics.
[8] F. Lohr,et al. Measurement of the proliferative activity of three different sublines of the Dunning rat prostate tumor R3327. , 1993, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[9] Olivier Clatz,et al. Biocomputing: numerical simulation of glioblastoma growth using diffusion tensor imaging , 2008, Physics in medicine and biology.
[10] B. Baguley. Tumor stem cell niches: a new functional framework for the action of anticancer drugs. , 2006, Recent patents on anti-cancer drug discovery.
[11] D. Mankoff,et al. Positron-emission tomographic imaging of cancer: glucose metabolism and beyond. , 2001, Seminars in radiation oncology.
[12] Michael J. Welch,et al. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[13] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[14] M Magnano,et al. Effects of anatomical constraints on tumor growth. , 2001, Physical review. E, Statistical, nonlinear, and soft matter physics.
[15] Konstantina S. Nikita,et al. A computer simulation of in vivo tumour growth and response to radiotherapy: New algorithms and parametric results , 2006, Comput. Biol. Medicine.
[16] T L Phillips,et al. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. , 1993, Radiation research.
[17] P. Harari,et al. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] J. Moore,et al. Radiation response and cure rate of human colon adenocarcinoma spheroids of different size: the significance of hypoxia on tumor control modelling. , 2001, International journal of radiation oncology, biology, physics.
[19] Brian W. Pogue,et al. Estimation of Oxygen Distribution in RIF-1 Tumors by Diffusion Model-Based Interpretation of Pimonidazole Hypoxia and Eppendorf Measurements , 2001, Radiation research.
[20] D. Brizel,et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] Jelena Pjesivac-Grbovic,et al. A multiscale model for avascular tumor growth. , 2005, Biophysical journal.
[22] R. Hill. Tumor progression: Potential role of unstable genomic changes , 1990, Cancer and Metastasis Reviews.
[23] T. Alper,et al. Cellular radiobiology. , 1960, Annual review of nuclear science.
[24] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[25] Y. Fujibayashi,et al. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] S. Schnell,et al. A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies , 2006, Theoretical Biology and Medical Modelling.
[27] Nikolaos K. Uzunoglu,et al. A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide , 2006, IEEE Transactions on Biomedical Engineering.
[28] Christian P Karger,et al. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation , 2007, Physics in medicine and biology.
[29] Y. Fujibayashi,et al. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] M. Weil,et al. An equation for the oxygen hemoglobin dissociation curve. , 1973, Journal of applied physiology.
[31] Peter Peschke,et al. Modeling and Computer Simulations of Tumor Growth and Tumor Response to Radiotherapy , 2004, Radiation research.
[32] P. Monaghan,et al. Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck. , 1981, British journal of cancer.
[33] M Kardar,et al. Dynamics of tumor growth and combination of anti-angiogenic and cytotoxic therapies , 2007, Physics in medicine and biology.
[34] P. Vaupel,et al. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.
[35] B. Wouters,et al. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.
[36] M. Martel,et al. Fractionated regimens for stereotactic radiotherapy of recurrent tumors in the brain. , 1991, International journal of radiation oncology, biology, physics.
[37] J. F. De Los Santos,et al. Anemia correction in malignancy management: threat or opportunity? , 2007, Gynecologic oncology.
[38] TIKVAH ALPER,et al. Role of Oxygen in Modifying the Radiosensitivity of E. Coli B. , 1956, Nature.
[39] J. Nilsson. Accurate description of heterogeneous tumors for biologically optimized radiation therapy , 2005 .
[40] Otto Muzik,et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography , 1998, Nature Medicine.
[41] S Mutic,et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. , 2001, International journal of radiation oncology, biology, physics.
[42] G. Dalrymple,et al. Initial studies with a line of radioresistant rat tumor cells. , 1974, Radiation research.
[43] O. S. Nielsen,et al. Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations , 2001, British Journal of Cancer.
[44] P Vaupel,et al. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.
[45] E. T. Gawlinski,et al. A Cellular Automaton Model of Early Tumor Growth and Invasion: The Effects of Native Tissue Vascularity and Increased Anaerobic Tumor Metabolism , 2001 .
[46] Mark A Mintun,et al. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. , 2003, International journal of radiation oncology, biology, physics.
[47] Konstantina S. Nikita,et al. Modeling tumor growth and irradiation response in vitro-a combination of high-performance computing and Web-based technologies including VRML visualization , 2001, IEEE Transactions on Information Technology in Biomedicine.
[48] P. Harari,et al. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). , 2002, Cancer research.
[49] E. Hall,et al. Radiobiology for the radiologist , 1973 .
[50] C. Ling,et al. Radiation-induced apoptosis: effects of cell age and dose fractionation. , 1995, Cancer research.
[51] H. Frieboes,et al. Predictive oncology: A review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growth , 2007, NeuroImage.
[52] M. Dorie,et al. Tumor oxygenation and reoxygenation during radiation therapy: their importance in predicting tumor response. , 1986, International journal of radiation oncology, biology, physics.
[53] N. Johnson,et al. DNA damage-inducible genes as biomarkers for exposures to environmental agents. , 1997, Environmental health perspectives.
[54] J F Fowler,et al. Biological Factors Influencing Optimum Fractionation in Radiation Therapy , 2001, Acta oncologica.
[55] T Ido,et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] Morand Piert,et al. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[57] G. Hanks,et al. Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation. , 2001, Seminars in radiation oncology.
[58] Y Yonekura,et al. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[59] G. Steel,et al. Basic Clinical Radiobiology , 1997 .
[60] H D Thames,et al. Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma? , 1990, International journal of radiation biology.
[61] J H Hendry,et al. A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity. , 1998, International journal of radiation oncology, biology, physics.
[62] H. Withers,et al. Four R's of radiotherapy , 1975 .
[63] R. Pötter,et al. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[64] V P Antipas,et al. A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density. , 2006, The British journal of radiology.
[65] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[66] G Powathil,et al. Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy , 2007, Physics in medicine and biology.
[67] Georgios S Stamatakos,et al. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation. , 2004, Journal of theoretical biology.
[68] M J Welch,et al. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[69] E. Rofstad,et al. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. , 1999, International journal of radiation biology.
[70] J Denekamp,et al. Theoretical simulation of oxygen tension measurement in tissues using a microelectrode: I. The response function of the electrode. , 2001, Physiological measurement.